\documentclass[10pt,a4paper]{article}

% Packages
\usepackage{fancyhdr}           % For header and footer
\usepackage{multicol}           % Allows multicols in tables
\usepackage{tabularx}           % Intelligent column widths
\usepackage{tabulary}           % Used in header and footer
\usepackage{hhline}             % Border under tables
\usepackage{graphicx}           % For images
\usepackage{xcolor}             % For hex colours
%\usepackage[utf8x]{inputenc}    % For unicode character support
\usepackage[T1]{fontenc}        % Without this we get weird character replacements
\usepackage{colortbl}           % For coloured tables
\usepackage{setspace}           % For line height
\usepackage{lastpage}           % Needed for total page number
\usepackage{seqsplit}           % Splits long words.
%\usepackage{opensans}          % Can't make this work so far. Shame. Would be lovely.
\usepackage[normalem]{ulem}     % For underlining links
% Most of the following are not required for the majority
% of cheat sheets but are needed for some symbol support.
\usepackage{amsmath}            % Symbols
\usepackage{MnSymbol}           % Symbols
\usepackage{wasysym}            % Symbols
%\usepackage[english,german,french,spanish,italian]{babel}              % Languages

% Document Info
\author{Thomas Von Chao (chautommy93)}
\pdfinfo{
  /Title (heart-failure.pdf)
  /Creator (Cheatography)
  /Author (Thomas Von Chao (chautommy93))
  /Subject (Heart Failure Cheat Sheet)
}

% Lengths and widths
\addtolength{\textwidth}{6cm}
\addtolength{\textheight}{-1cm}
\addtolength{\hoffset}{-3cm}
\addtolength{\voffset}{-2cm}
\setlength{\tabcolsep}{0.2cm} % Space between columns
\setlength{\headsep}{-12pt} % Reduce space between header and content
\setlength{\headheight}{85pt} % If less, LaTeX automatically increases it
\renewcommand{\footrulewidth}{0pt} % Remove footer line
\renewcommand{\headrulewidth}{0pt} % Remove header line
\renewcommand{\seqinsert}{\ifmmode\allowbreak\else\-\fi} % Hyphens in seqsplit
% This two commands together give roughly
% the right line height in the tables
\renewcommand{\arraystretch}{1.3}
\onehalfspacing

% Commands
\newcommand{\SetRowColor}[1]{\noalign{\gdef\RowColorName{#1}}\rowcolor{\RowColorName}} % Shortcut for row colour
\newcommand{\mymulticolumn}[3]{\multicolumn{#1}{>{\columncolor{\RowColorName}}#2}{#3}} % For coloured multi-cols
\newcolumntype{x}[1]{>{\raggedright}p{#1}} % New column types for ragged-right paragraph columns
\newcommand{\tn}{\tabularnewline} % Required as custom column type in use

% Font and Colours
\definecolor{HeadBackground}{HTML}{333333}
\definecolor{FootBackground}{HTML}{666666}
\definecolor{TextColor}{HTML}{333333}
\definecolor{DarkBackground}{HTML}{AD0A15}
\definecolor{LightBackground}{HTML}{FCF7F7}
\renewcommand{\familydefault}{\sfdefault}
\color{TextColor}

% Header and Footer
\pagestyle{fancy}
\fancyhead{} % Set header to blank
\fancyfoot{} % Set footer to blank
\fancyhead[L]{
\noindent
\begin{multicols}{3}
\begin{tabulary}{5.8cm}{C}
    \SetRowColor{DarkBackground}
    \vspace{-7pt}
    {\parbox{\dimexpr\textwidth-2\fboxsep\relax}{\noindent
        \hspace*{-6pt}\includegraphics[width=5.8cm]{/web/www.cheatography.com/public/images/cheatography_logo.pdf}}
    }
\end{tabulary}
\columnbreak
\begin{tabulary}{11cm}{L}
    \vspace{-2pt}\large{\bf{\textcolor{DarkBackground}{\textrm{Heart Failure Cheat Sheet}}}} \\
    \normalsize{by \textcolor{DarkBackground}{Thomas Von Chao (chautommy93)} via \textcolor{DarkBackground}{\uline{cheatography.com/178810/cs/47692/}}}
\end{tabulary}
\end{multicols}}

\fancyfoot[L]{ \footnotesize
\noindent
\begin{multicols}{3}
\begin{tabulary}{5.8cm}{LL}
  \SetRowColor{FootBackground}
  \mymulticolumn{2}{p{5.377cm}}{\bf\textcolor{white}{Cheatographer}}  \\
  \vspace{-2pt}Thomas Von Chao (chautommy93) \\
  \uline{cheatography.com/chautommy93} \\
  \end{tabulary}
\vfill
\columnbreak
\begin{tabulary}{5.8cm}{L}
  \SetRowColor{FootBackground}
  \mymulticolumn{1}{p{5.377cm}}{\bf\textcolor{white}{Cheat Sheet}}  \\
   \vspace{-2pt}Not Yet Published.\\
   Updated 18th February, 2026.\\
   Page {\thepage} of \pageref{LastPage}.
\end{tabulary}
\vfill
\columnbreak
\begin{tabulary}{5.8cm}{L}
  \SetRowColor{FootBackground}
  \mymulticolumn{1}{p{5.377cm}}{\bf\textcolor{white}{Sponsor}}  \\
  \SetRowColor{white}
  \vspace{-5pt}
  %\includegraphics[width=48px,height=48px]{dave.jpeg}
  Measure your website readability!\\
  www.readability-score.com
\end{tabulary}
\end{multicols}}




\begin{document}
\raggedright
\raggedcolumns

% Set font size to small. Switch to any value
% from this page to resize cheat sheet text:
% www.emerson.emory.edu/services/latex/latex_169.html
\footnotesize % Small font.

\begin{multicols*}{2}

\begin{tabularx}{8.4cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{8.4cm}}{\bf\textcolor{white}{GDMT for Heart Failure Stage C}}  \tn
\SetRowColor{LightBackground}
\mymulticolumn{1}{p{8.4cm}}{\vspace{1px}\centerline{\includegraphics[width=5.1cm]{/web/www.cheatography.com/public/uploads/chautommy93_1771382018_Screenshot 2026-02-17 192155.png}}} \tn 
\hhline{>{\arrayrulecolor{DarkBackground}}-}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{8.4cm}{x{3.04 cm} x{4.96 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{8.4cm}}{\bf\textcolor{white}{GDMT for Heart Failure}}  \tn
% Row 0
\SetRowColor{LightBackground}
\{\{ac\}\}{\bf{Class}}\{\{bb=3\}\} & \{\{ac\}\}{\bf{Place of Therapy}}\{\{bb=3\}\} \tn 
% Row Count 2 (+ 2)
% Row 1
\SetRowColor{white}
ARNIs & Preferred first-line RAAS agent for ALL patients with Stage C HFrEF (NYHA class II–IV) \tn 
% Row Count 6 (+ 4)
% Row 2
\SetRowColor{LightBackground}
ACEIs & Recommended for patients who cannot tolerate ARNi (e.g., due to cost, prior angioedema to ARNi components, or hemodynamic limitations). \tn 
% Row Count 12 (+ 6)
% Row 3
\SetRowColor{white}
ARBs & Second-line RAAS therapy, used when patients cannot tolerate ACEi (most commonly due to cough) or ARNi. \tn 
% Row Count 17 (+ 5)
% Row 4
\SetRowColor{LightBackground}
Beta-Blockers & Mandatory component of GDMT for all patients with Stage C HFrEF (NYHA class I–IV) who have current or previous symptoms. \tn 
% Row Count 23 (+ 6)
% Row 5
\SetRowColor{white}
MRAs & Recommended for all eligible patients with HFrEF and NYHA class II–IV symptoms. \tn 
% Row Count 27 (+ 4)
% Row 6
\SetRowColor{LightBackground}
SGLT2is & Recommended for ALL patients with symptomatic HFrEF regardless of the presence of T2DM. \tn 
% Row Count 31 (+ 4)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{8.4cm}{x{3.04 cm} x{4.96 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{8.4cm}}{\bf\textcolor{white}{GDMT for Heart Failure (cont)}}  \tn
% Row 7
\SetRowColor{LightBackground}
Loop \& Thiazide Diuretic & Primary agents for decongestion in Stage C HFrEF, used to manage volume overload, relieve dyspnea, edema, and orthopnea. \tn 
% Row Count 5 (+ 5)
\hhline{>{\arrayrulecolor{DarkBackground}}--}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{8.4cm}{x{4 cm} x{4 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{8.4cm}}{\bf\textcolor{white}{Monitoring Parameters}}  \tn
% Row 0
\SetRowColor{LightBackground}
\{\{ac\}\}{\bf{Drug Class}}\{\{bb=3\}\} & \{\{ac\}\}{\bf{Monitoring Parameter}}\{\{bb=3\}\} \tn 
% Row Count 2 (+ 2)
% Row 1
\SetRowColor{white}
ARNIs & • Electrolytes (K⁺, Na⁺), SCr/eGFR \{\{nl\}\} • BP | HR | S/Sx of HF \{\{nl\}\} \tn 
% Row Count 6 (+ 4)
% Row 2
\SetRowColor{LightBackground}
ACEIs / ARBs & • Serum electrolytes (K⁺) at baseline, 1–2 weeks after \seqsplit{initiation/titration}, and every 3–6 months \{\{nl\}\} • Vitals (BP, HR) \{\{nl\}\} • Renal function (SCr, BUN) \{\{nl\}\} \tn 
% Row Count 15 (+ 9)
% Row 3
\SetRowColor{white}
Beta-Blockers & • Vitals (HR, BP)  \{\{nl\}\} • Fluid status, S/Sx at each titration visits \{\{nl\}\} • Avoid abrupt withdrawal \{\{nl\}\} \tn 
% Row Count 21 (+ 6)
% Row 4
\SetRowColor{LightBackground}
MRAs & • Serum K⁺ and SCr/eGFR w/in 1 week of initiation and after each dose adjustment; then monthly for 3 months; then every 3–6 months when stable.\{\{nl\}\} • Recheck with any intercurrent illness, dehydration, or medication changes \{\{nl\}\} \tn 
% Row Count 33 (+ 12)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{8.4cm}{x{4 cm} x{4 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{8.4cm}}{\bf\textcolor{white}{Monitoring Parameters (cont)}}  \tn
% Row 5
\SetRowColor{LightBackground}
SGLT2is & • eGFR, BP, signs of volume depletion, UTI \{\{nl\}\} • Glucose in diabetic patients \{\{nl\}\} • Hold if patient is NPO or acutely ill \{\{nl\}\} \tn 
% Row Count 7 (+ 7)
% Row 6
\SetRowColor{white}
Loop \& Thiazide Diuretics & • Daily weights (patient self-monitoring), BP, HR \{\{nl\}\} • BMP (Na⁺, K⁺, Mg$^{\textrm{2}}$⁺, BUN, SCr) at initiation and periodically \{\{nl\}\} • Electrolytes more frequently when doses adjusted or with illness \{\{nl\}\} \tn 
% Row Count 18 (+ 11)
% Row 7
\SetRowColor{LightBackground}
\seqsplit{Hydralazine/isosorbide} dinitrate (H-ISDN) & • Vitals (BP, HR); CBC periodically \{\{nl\}\} • S/Sx of Lupus (ANA if clinically suspected), adherence assessment given pill burden \{\{nl\}\} \tn 
% Row Count 25 (+ 7)
% Row 8
\SetRowColor{white}
Ivabradine & • Resting HR (target 55–60 bpm) \{\{nl\}\} • ECG rhythm (monitor for AF), BP \{\{nl\}\} • Visual symptoms \{\{nl\}\} \tn 
% Row Count 31 (+ 6)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{8.4cm}{x{4 cm} x{4 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{2}{x{8.4cm}}{\bf\textcolor{white}{Monitoring Parameters (cont)}}  \tn
% Row 9
\SetRowColor{LightBackground}
Vericiguat & • BP , HR, S/Sx HF \{\{nl\}\} • CBC (Hgb/Hct), Renal function \{\{nl\}\} \tn 
% Row Count 4 (+ 4)
% Row 10
\SetRowColor{white}
Digoxin & • Digoxin concentration (target 0.5–\textless{}0.9 ng/mL; check 6–8 hours post-dose at steady state) \{\{nl\}\} • Renal function (SCr, eGFR), electrolytes (K⁺, Mg$^{\textrm{2}}$⁺, Ca$^{\textrm{2}}$⁺), ECG (PR interval, rhythm) \{\{nl\}\} • Symptoms of toxicity at every visit \{\{nl\}\} \tn 
% Row Count 17 (+ 13)
\hhline{>{\arrayrulecolor{DarkBackground}}--}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{8.4cm}{x{2.584 cm} x{2.508 cm} x{2.508 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{3}{x{8.4cm}}{\bf\textcolor{white}{Dosing of 4 Pillars Therapy}}  \tn
% Row 0
\SetRowColor{LightBackground}
\{\{ac\}\}{\bf{Agents}}\{\{bb=3\}\} & \{\{ac\}\}{\bf{Starting Dose}}\{\{bb=3\}\} & \{\{ac\}\}{\bf{Target Dose}}\{\{bb=3\}\} \tn 
% Row Count 3 (+ 3)
% Row 1
\SetRowColor{white}
\{\{ar\}\} Sacubitril/\{\{nl\}\}Valsartan & 49 mg/51 mg BID & 97 mg/103 mg BID \tn 
% Row Count 6 (+ 3)
% Row 2
\SetRowColor{LightBackground}
\{\{ar\}\} Captopril \{\{nl\}\} Enalapril \{\{nl\}\} Lisinopril \{\{nl\}\} Fosinopril \{\{nl\}\} Ramipril \{\{nl\}\} Trandolapril \{\{nl\}\} Perindopril \{\{nl\}\} Quinapril & 6.25 mg TID \{\{nl\}\} 2.5 mg BID \{\{nl\}\} 2.5–5 mg daily \{\{nl\}\} 5–10 mg daily \{\{nl\}\} 1.25–2.5 mg daily \{\{nl\}\} 1 mg daily \{\{nl\}\} 2 mg daily \{\{nl\}\} 5 mg BID & 50 mg TID \{\{nl\}\} 10–20 mg BID \{\{nl\}\} 20–40 mg daily \{\{nl\}\} 40 mg daily \{\{nl\}\} 10 mg daily \{\{nl\}\} 4 mg daily \{\{nl\}\} 8–16 mg daily \{\{nl\}\} 20 mg BID \tn 
% Row Count 18 (+ 12)
% Row 3
\SetRowColor{white}
\{\{ar\}\} Candesartan \{\{nl\}\} Losartan \{\{nl\}\} Valsartan \{\{nl\}\} & 4–8 mg daily \{\{nl\}\} 25–50 mg daily \{\{nl\}\} 20–40 mg daily & 32 mg daily \{\{nl\}\} 50–150 mg daily \{\{nl\}\} 160 mg BID \tn 
% Row Count 23 (+ 5)
% Row 4
\SetRowColor{LightBackground}
\{\{ar\}\} Bisoprolol \{\{nl\}\} Carvedilol \{\{nl\}\} Carvedilol CR \{\{nl\}\} Metoprolol succinate ER & 1.25 mg daily \{\{nl\}\} 3.125 mg BID \{\{nl\}\} 10 mg daily \{\{nl\}\} 12.5–25 mg daily & 10 mg daily \{\{nl\}\} 25–50 mg BID \{\{nl\}\} 80 mg daily \{\{nl\}\} 200 mg daily \tn 
% Row Count 30 (+ 7)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{8.4cm}{x{2.584 cm} x{2.508 cm} x{2.508 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{3}{x{8.4cm}}{\bf\textcolor{white}{Dosing of 4 Pillars Therapy (cont)}}  \tn
% Row 5
\SetRowColor{LightBackground}
\{\{ar\}\} \seqsplit{Spironolactone} \{\{nl\}\} Eplerenone \{\{nl\}\} & 12.5–25 mg daily \{\{nl\}\} 25–50 mg daily & 25 mg daily \{\{nl\}\} 50 mg daily \tn 
% Row Count 4 (+ 4)
% Row 6
\SetRowColor{white}
\{\{ar\}\} \seqsplit{Dapagliflozin} \{\{nl\}\} \seqsplit{Empagliflozin} & 10 mg once daily & Fixed dose; no titration required \tn 
% Row Count 8 (+ 4)
\hhline{>{\arrayrulecolor{DarkBackground}}---}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{8.4cm}{x{1.8 cm} x{1.8 cm} x{1.8 cm} x{1.8 cm} }
\SetRowColor{DarkBackground}
\mymulticolumn{4}{x{8.4cm}}{\bf\textcolor{white}{DIURETICS: LOOP AND THIAZIDE}}  \tn
% Row 0
\SetRowColor{LightBackground}
\{\{ac\}\}{\bf{Agent}} & \{\{ac\}\}{\bf{Initial TDD}} & \{\{ac\}\}{\bf{Max TDD}} & \{\{ac\}\}{\bf{DOA}} \tn 
% Row Count 3 (+ 3)
% Row 1
\SetRowColor{white}
\{\{bt=3\}\}Loop Diuretics\{\{bb=3\}\} & \{\{bt=3\}\}\{\{bb=3\}\} & \{\{bt=3\}\}\{\{bb=3\}\} & \{\{bt=3\}\}\{\{bb=3\}\} \tn 
% Row Count 6 (+ 3)
% Row 2
\SetRowColor{LightBackground}
\{\{ar\}\} \seqsplit{Furosemide} \{\{nl\}\} \seqsplit{Bumetanide} \{\{nl\}\} Torsemide & 20–40 mg QD-BID \{\{nl\}\} 0.5–1.0 mg QD-BID \{\{nl\}\} 10–20 mg QD & 600 mg \{\{nl\}\} 10 mg \{\{nl\}\} 200 mg & 6–8 hours \{\{nl\}\} 4–6 hours \{\{nl\}\} 12–16 hours \tn 
% Row Count 13 (+ 7)
% Row 3
\SetRowColor{white}
\{\{bt=3\}\}Thiazide Diuretics\{\{bb=3\}\} & \{\{bt=3\}\}\{\{bb=3\}\} & \{\{bt=3\}\}\{\{bb=3\}\} & \{\{bt=3\}\}\{\{bb=3\}\} \tn 
% Row Count 17 (+ 4)
% Row 4
\SetRowColor{LightBackground}
\{\{ar\}\} \seqsplit{Hydrochlorothiazide} \{\{nl\}\} \seqsplit{Metolazone} \{\{nl\}\} \seqsplit{Chlorthalidone} \{\{nl\}\} \seqsplit{Indapamide} & 25 mg QD-BID \{\{nl\}\} 2.5 mg QD \{\{nl\}\} 12.5–25 mg QD \{\{nl\}\} 2.5 mg QD & 200 mg \{\{nl\}\} 20 mg \{\{nl\}\} 100 mg \{\{nl\}\} 5 mg & 6–12 hours \{\{nl\}\} 12–24 hours \{\{nl\}\} 24–72 hours \{\{nl\}\} 36 hours \tn 
% Row Count 26 (+ 9)
\hhline{>{\arrayrulecolor{DarkBackground}}----}
\end{tabularx}
\par\addvspace{1.3em}


% That's all folks
\end{multicols*}

\end{document}